<DOC>
	<DOCNO>NCT02119793</DOCNO>
	<brief_summary>This study purpose evaluate long-term efficacy safety repeat treatment YVOIRE® contour inject anteromedial malar region subject complete LG-HACL014 study .</brief_summary>
	<brief_title>Extension Clinical Study Evaluate Long-term Efficacy Safety Repeat Treatment YVOIRE® Contour Injected Into Anteromedial Malar Region Subjects Who Have Completed LG-HACL014 Study</brief_title>
	<detailed_description />
	<criteria>Eligible subject complete LGHACL014 study Have anteromedial malar region volume loss least onepoint bad MFAS compare 2 week treatment LGHACL014 study Accept obligation receive mid facial procedure treatment study Signed informed consent Those fall one follow 3 case 1 . Males females surgically sterile 2 . PostMenopausal females 45 year age 2 year last menstruation 3 . Fertile premenopausal female male without surgical sterilization , agree use least two contraception method ( one barrier method must include ) 14 day repeat treatment investigational device avoid pregnancy Have history hypertrophic scar keloids Other criterion identify protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>